Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Japanese encephalitis virus (JEV) infectious clone with luciferase gene and building method and application thereof

A technology of luciferase gene and infectious clone, applied in the field of preparation of JEV infectious clone

Inactive Publication Date: 2014-01-08
WUHAN INST OF VIROLOGY CHINESE ACADEMY OF SCI
View PDF1 Cites 20 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

So far, there is no specific antiviral drug to treat Japanese encephalitis caused by JEV infection. Symptomatic and supportive therapy are mainly used

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Japanese encephalitis virus (JEV) infectious clone with luciferase gene and building method and application thereof
  • Japanese encephalitis virus (JEV) infectious clone with luciferase gene and building method and application thereof
  • Japanese encephalitis virus (JEV) infectious clone with luciferase gene and building method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0067] A method for constructing a JEV virus infectious clone with a luciferase gene, the steps of which are:

[0068] 1. Segmented synthesis of the genome sequence of JEV-SA14 virus strain:

[0069] Construction of cDNA infectious clones with full-length JEV genome: select the JEV-SA14 (GenBank No.U14163.1) virus strain sequence, divide it into four fragments for gene synthesis (Golden Wisdom Biotechnology Co., Ltd.), and the four fragments are respectively Name them Fragment A, Fragment B, Fragment C, and Fragment D. Fragment A includes the sequence of "T7+genome 1-3450nt", fragment B includes the sequence of "genome 3446-5581nt", fragment C includes the sequence of "genome 5576-9136nt", and fragment D includes the sequence of "genome 9121-10976nt+HDVR" sequence. "T7" in Fragment A is a promoter, the sequence is shown in SEQ ID NO.2, and it is located before the 5'UTR of the viral genome to ensure that the constructed cDNA is transcribed in vitro to obtain genomic RNA. "H...

Embodiment 2

[0085] Infectious clones of JEV virus with luciferase gene successfully rescued the virus with the same growth tendency as wild-type virus

[0086]1. Linearization and phenol-chloroform extraction of plasmids: each take 10 μg of plasmid pACYC-JEV-FL and plasmid pACYC-Rl uc-JEV-FL, digest with XhoI (described above), digest at 37°C for two hours, and After 1% agarose gel electrophoresis to identify the complete digestion, add 100 μl of saturated phenol (purchased from Sinopharm Chemical Reagent Company) to the digested product, shake and mix, centrifuge at 17,000g for 5min, draw the upper layer into a new centrifuge tube, And add 100μl sterile water to the original centrifuge tube, shake and mix well, centrifuge at 17000g for 5min; absorb the upper layer liquid and combine with the liquid obtained in the previous step (total volume is about 200μl), add 200μl chloroform (purchased from Sinopharm Chemical Reagent Company) and mix well, 17000g Centrifuge for 5 minutes; draw the up...

Embodiment 3

[0091] A kind of application of JEV infectious clone with luciferase gene in antiviral drug screening, its steps are:

[0092] 1. Inhibitory effect of NITD008 on Rluc-JEV: Inoculate 1×10 in each well of a 12-well cell culture plate 5 BHK-21 cells at 37°C, 5% CO 2 Under culture conditions, when the confluence reached 60%, add Rluc-J EV virus solution to each well, the MOI was 0.01, 37°C, 5% CO 2 After 1 hour of adsorption in the incubator, the virus liquid in each well was discarded with a pipette tip, and NITD008 serially diluted with DMEM medium containing 2% fetal bovine serum (concentrations of 0, 0.11, 1, 3, 9 and 27μM), at 37℃, 5%CO 2 After culturing in the incubator for 48 hours, discard the supernatant in the wells, add 1ml PBS to the wells, discard the PBS in the wells, add 200μl cell lysate to treat the cells and mix the cell lysates in the wells, take 20μl in In a white 96-well plate, 50 μl of substrate was added, and the activity of Rluc was detected using a mult...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a Japanese encephalitis virus (JEV) infectious clone with a luciferase gene, and a building method and application thereof. The JEV infectious clone with the luciferase gene is prepared by the following steps: (1) sectional synthesis of a JEV SA14 strain gene sequence; (2) assembling and building of the JEV infectious clone; (3) building of the JEV infectious clone with the luciferase gene. It is proved that a Rluc-JEV report virus with the same growth tendency as the JEV virus can be saved by the JEV infectious clone with the luciferase gene built by the method, and the JEV infectious clone has wide application value in the aspects of an animal model, virus replication and pathogenesis, drug screening and drug action mechanism, live animal imaging and vaccine evaluation and the like through the experiments of immunofluorescence, Rluc activity detection, virus bacteriophage plaque, drug inhibition, live animal imaging, vaccine evaluation and the like.

Description

technical field [0001] The invention belongs to the field of biotechnology, and in particular relates to a JEV infectious clone with a luciferase gene, a method for preparing a JEV infectious clone with a luciferase gene, and the Rluc- Application of JEV reporter virus in antiviral drug screening, animal live imaging and Japanese encephalitis vaccine evaluation. Background technique [0002] Japanese encephalitis virus (JEV) is the pathogen of Japanese encephalitis (referred to as Japanese encephalitis). The virus is transmitted through mosquito bites. The virus enters the human body along with the mosquito saliva, causing central nervous system damage, fatality rate and fatality rate. The disability rate is high, and as a kind of infectious disease that takes children as a high-risk group, JE seriously endangers children's physical and mental health. JE is mainly prevalent in Asia, and began to spread to Australia in 1995. In recent years, the epidemic area has covered 24 ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12N15/85C12N15/66A61K49/00G01N21/64C12Q1/66
Inventor 张波李晓丹秦成峰李晓峰袁志明邓成林单超叶寒青
Owner WUHAN INST OF VIROLOGY CHINESE ACADEMY OF SCI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com